Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
Business Wire•15/10/2026•08:00 ET
0
Key Highlights
- ➤Alnylam will report Q3 2026 financial results October 29 before markets open
- ➤Management will discuss Q3 results and future expectations during an 8:30 am ET call
- ➤Live and archived webcasts will be available through Alnylam’s website
Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2026 on Thursday, October 29, 2026, before the U.S. financial markets open.
Get started
Create a free account to read the full story.